Surgical Resection and Liver Transplantation for Hepatocellular Carcinoma

Clinics in Liver Disease

Volumn 19, Issue 2, 2015, Pages 381-399

  Akoad, Mohamed E ^a   Pomfret, Elizabeth A ^a  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

Downstaging; Hepatic resection; Hepatocellular carcinoma; Liver transplantation; Living donor liver transplantation; Locoregional therapy

Indexed keywords

ABLATION THERAPY; CANCER PATIENT; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CLINICAL EVALUATION; DIGESTIVE SYSTEM DISEASE ASSESSMENT; HUMAN; LIVER CELL CARCINOMA; LIVER GRAFT; LIVER RESECTION; LIVER TRANSPLANTATION; LIVING DONOR; MILAN CRITERIA; OUTCOME ASSESSMENT; PREOPERATIVE TREATMENT; REVIEW; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW (TOPIC); UNIVERSITY OF CALIFORNIA AT SAN FRANCISCO CRITERIA; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHEMOEMBOLIZATION; LIVER NEOPLASMS; PATHOLOGY; PATIENT SELECTION; PROCEDURES; TREATMENT OUTCOME; TUMOR RECURRENCE;

ANTINEOPLASTIC AGENT;

ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHEMOEMBOLIZATION, THERAPEUTIC; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LIVING DONORS; NEOPLASM RECURRENCE, LOCAL; PATIENT SELECTION; TREATMENT OUTCOME;

EID: 84928823189     PISSN: 10893261     EISSN: 15578224     Source Type: Journal    
DOI: 10.1016/j.cld.2015.01.007     Document Type: Review

References (68)

1. Hu R.H., Lee P.H., Yu S.C., et al. Surgical resection for recurrent hepatocellular carcinoma: prognosis and analysis of risk factors. Surgery 1996, 120(1):23-29.
2. Bosch F.X., Ribes J., Borras J. Epidemiology of primary liver cancer. Semin Liver Dis 1999, 19:271-285.
3. Bismuth H., Chiche L., Castaing D. Surgical treatment of hepatocellular carcinomas in noncirrhotic liver: experience with 68 liver resections. World J Surg 1995, 19(1):35-41.
4. Fong Y., Sun R.L., Jarnagin W., et al. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 1999, 229(6):790.
5. Llovet J.M., Fuster J., Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999, 30(6):1434-1440.
6. Bruix J., Castells A., Bosch J., et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 1996, 111(4):1018-1022.
7. Teh S.H., Christein J., Donohue J., et al. Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: Model of End-Stage Liver Disease (MELD) score predicts perioperative mortality. JGastrointest Surg 2005, 9(9):1207-1215.
8. Bismuth H., Chiche L., Adam R., et al. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg 1993, 218(2):145-151.
9. Fuster J., Garcia-Valdecasas J.C., Grande L., et al. Hepatocellular carcinoma and cirrhosis-results of surgical treatment in a European series. Ann Surg 1996, 223(3):297-302.
10. Iwatsuki S., Starzl T.E., Sheahan D.G., et al. Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg 1991, 214(3):221-229.
11. Roayaie S., Haim M.B., Emre S., et al. Comparison of surgical outcomes for hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a Western experience. Ann Surg Oncol 2000, 7(10):764-770.
12. Suenaga M., Nakao A., Harada A., et al. Hepatic resection for hepatocellular carcinoma. World J Surg 1992, 16(1):97-105.
13. Sasaki Y., Imaoka S., Masutani S., et al. Influence of coexisting cirrhosis on long-term prognosis after surgery in patients with hepatocellular carcinoma. Surgery 1992, 112(3):515-521.
14. Lai E.C., Fan S.T., Lo C.M., et al. Hepatic resection for hepatocellular carcinoma. An audit of 343 patients. Ann Surg 1995, 221(3):291-298.
15. Schwartz M.E., Sung M., Mor E., et al. Amultidisciplinary approach to hepatocellular carcinoma in patients with cirrhosis. JAm Coll Surg 1995, 180(5):596-603.
16. Nagasue N., Ono T., Yamanoi A., et al. Prognostic factors and survival after hepatic resection for hepatocellular carcinoma without cirrhosis. Br J Surg 2001, 88(4):515-522.
17. Poon R.T., Fan S.T., Lo C.M., et al. Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 2002, 235(3):373-382.
18. Belghiti J., Regimbeau J.M., Durand F., et al. Resection of hepatocellular carcinoma: a European experience on 328 cases. Hepatogastroenterology 2002, 49(43):41-46.
19. Chen M.F., Tsai H.P., Jeng L.B., et al. Prognostic factors after resection for hepatocellular carcinoma in noncirrhotic livers: univariate and multivariate analysis. World J Surg 2003, 27(4):443-447.
20. Laurent C., Blanc J.F., Nobili S., et al. Prognostic factors and longterm survival after hepatic resection for hepatocellular carcinoma originating from noncirrhotic liver. JAm Coll Surg 2005, 201(5):656-662.
21. Bège T., Le Treut Y.P., Hardwigsen J., et al. Prognostic factors after resection for hepatocellular carcinoma in nonfibrotic or moderately fibrotic liver. A 116-case European series. JGastrointest Surg 2007, 11(5):619-625.
22. Taura K., Ikai I., Hatano E., et al. Influence of coexisting cirrhosis on outcomes after partial hepatic resection for hepatocellular carcinoma fulfilling the Milan criteria: an analysis of 293 patients. Surgery 2007, 142(5):685-694.
23. Cherqui D., Laurent A., Mocellin N., et al. Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation. Ann Surg 2009, 250(5):738-746.
24. Lee K.K., Kim D.G., Moon I.S., et al. Liver transplantation versus liver resection for the treatment of hepatocellular carcinoma. JSurg Oncol 2010, 101(1):47-53.
25. Mazzaferro V., Regalia E., Doci R., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. NEngl J Med 1996, 334(11):693-699.
26. Huang Y.H., Wu J.C., Chen C.H., et al. Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area. Liver Int 2005, 25(2):236-241.
27. Kao W.Y., Su C.W., Chau G.Y., et al. Acomparison of prognosis between patients with hepatitis B and C virus-related hepatocellular carcinoma undergoing resection surgery. World J Surg 2011, 35(4):858-867.
28. Jaeck D., Bachellier P., Oussoultzoglou E., et al. Surgical resection of hepatocellular carcinoma. Post-operative outcome and long-term results in Europe: an overview. Liver Transpl 2004, 10(2 Suppl 1):S58-S63.
29. Finkelstein S.D., Marsh W., Demetris A.J., et al. Microdissection-based allelotyping discriminates de novo tumor from intrahepatic spread in hepatocellular carcinoma. Hepatology 2003, 37(4):871-879.
30. Margarit C., Escartín A., Castells L., et al. Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation. Liver Transpl 2005, 11(10):1242-1251.
31. Belghiti J., Cortes A., Abdalla E.K., et al. Resection prior to liver transplantation for hepatocellular carcinoma. Ann Surg 2003, 238(6):885-892.
32. Facciuto M.E., Koneru B., Rocca J.P., et al. Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation. Ann Surg Oncol 2008, 15(5):1383-1391.
33. Adam R., Azoulay D., Castaing D., et al. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy?. Ann Surg 2003, 238(4):508-518.
34. Belli G., Limongelli P., Fantini C., et al. Laparoscopic and open treatment of hepatocellular carcinoma in patients with cirrhosis. Br J Surg 2009, 96(9):1041-1048.
35. Tranchart H., Di Giuro G., Lainas P., et al. Laparoscopic resection for hepatocellular carcinoma: a matched-pair comparative study. Surg Endosc 2010, 24(5):1170-1176.
36. Cheung T.T., Poon R.T., Yuen W.K., et al. Long-term survival analysis of pure laparoscopic versus open hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a single-center experience. Ann Surg 2013, 257(3):506-511.
37. Mazzaferro V., Bhoori S., Sposito C., et al. Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience. Liver Transpl 2011, 17(Suppl 2):S44-S57.
38. Freeman R.B., Weisner R.H., Harper A., et al. The new liver allocation system: moving towards evidence-based transplantation policy. Liver Transpl 2002, 8(9):851-858.
39. Yao F.Y., Ferrell L., Bass N.M., et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001, 33(6):1394-1403.
40. Yao F.Y., Xiao L., Bass N.M., et al. Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging. Am J Transplant 2007, 7(11):2587-2596.
41. Duffy J.P., Vardanian A., Benjamin E., et al. Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA. Ann Surg 2007, 246(3):502-509.
42. Decaens T., Roudot-Thoraval F., Hadni-Bresson S., et al. Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time. Liver Transpl 2006, 12(12):1761-1769.
43. Volk M.L., Vijan S., Marrero J.A. Anovel model measuring the harm of transplanting hepatocellular carcinoma exceeding Milan criteria. Am J Transplant 2008, 8(4):839-846.
44. Pomfret E.A., Washburn K., Wald C., et al. Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States. Liver Transpl 2010, 16(3):262-278.
45. Lee S.G., Hwang S., Moon D.B., et al. Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large-volume center. Liver Transpl 2008, 14(7):935-945.
46. DuBay D., Sandroussi C., Sandhu L., et al. Liver transplantation for advanced hepatocellular carcinoma using poor tumor differentiation on biopsy as an exclusion criterion. Ann Surg 2011, 253(1):166-172.
47. Sugawara Y., Tamura S., Makuuchi M. Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series. Dig Dis 2007, 25(4):310-312.
48. Zheng S.S., Xu X., Wu J., et al. Liver transplantation for hepatocellular carcinoma: Hangzhou experiences. Transplantation 2008, 85(12):1726-1732.
49. Mazzaferro V., Llovet J.M., Miceli R., for Metroticket Investigator Study Group, et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 2009, 10(1):35-43.
50. Fisher R.A., Maluf D., Cotterell A.H., et al. Non-resective ablation therapy for hepatocellular carcinoma: effectiveness measured by intention-to-treat and dropout from liver transplant waiting list. Clin Transplant 2004, 18(5):502-512.
51. Maddala Y.K., Stadheim L., Andrews J.C., et al. Drop-out rates of patients with hepatocellular cancer listed for liver transplantation: outcome with chemoembolization. Liver Transpl 2004, 10(3):449-455.
52. Millonig G., Graziadei I.W., Freund M.C., et al. Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma. Liver Transpl 2007, 13(2):272-279.
53. Pompili M., Mirante V.G., Rondinara G., et al. Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: assessment of efficacy at explant analysis and of safety for tumor recurrence. Liver Transpl 2005, 11(9):1117-1126.
54. Freeman R.B., Edwards E.B., Harper A.M. Waiting list removal rates among patients with chronic and malignant liver diseases. Am J Transplant 2006, 6(6):1416-1421.
55. Lu D.S., Yu N.C., Raman S.S., et al. Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation. Hepatology 2005, 41(5):1130-1137.
56. Freeman R.B., Steffick D.E., Guidinger M.K., et al. Liver and intestine transplantation in the United States, 1997-2006. Am J Transplant 2008, 8(4 Pt 2):958-976.
57. Yao F.Y., Hirose R., LaBerge J.M., et al. Aprospective study on downstaging of hepatocellular carcinoma prior to liver transplantation. Liver Transpl 2005, 11(12):1505-1514.
58. Chapman W.C., Majella Doyle M.B., Stuart J.E., et al. Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation. Ann Surg 2008, 248(4):617-625.
59. Yao F.Y. Liver transplantation for hepatocellular carcinoma: beyond the Milan criteria. Am J Transplant 2008, 8(10):1982-1989.
60. Yao F.Y., Kerlan R.K., Hirose R., et al. Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis. Hepatology 2008, 48(3):819-827.
61. Figueras J., Ibañez L., Ramos E., et al. Selection criteria for liver transplantation in early-stage hepatocellular carcinoma with cirrhosis: results of a multicenter study. Liver Transpl 2001, 7(10):877-883.
62. Gordon-Weeks A.N., Snaith A., Petrinic T., et al. Systematic review of outcome of downstaging hepatocellular cancer before liver transplantation in patients outside the Milan criteria. Br J Surg 2011, 98(9):1201-1208.
63. Vakili K., Pomposelli J.J., Cheah Y.L., et al. Living donor liver transplantation for hepatocellular carcinoma: increased recurrence but improved survival. Liver Transpl 2009, 15(12):1861-1866.
64. Kulik L.M., Fisher R.A., Rodrigo D.R., et al. Outcomes of living and deceased donor liver transplant recipients with hepatocellular carcinoma: results of the A2ALL cohort. Am J Transplant 2012, 12(11):2997-3007.
65. Barr M., Belghiti J., Villamil F., et al. Areport of the Vancouver Forum on the care of the live organ donor: lung, liver, pancreas, and intestine data and medical guidelines. Transplantation 2008, 10(81):1373-1385.
66. Ghobrial R.M., Freise C.E., Trotter J.F., et al. Donor morbidity after living donation for liver transplantation. Gastroenterology 2008, 135(2):468-476.
67. Abecassis M.M., Fisher R.A., Olthoff K.M., the A2ALL Study Group, et al. Complications of living donor hepatic lobectomy - a comprehensive report. Am J Transplant 2012, 12(5):1208-1217.
68. Miller C.M. Ethical dimensions of living donation: experience with living liver donation. Transplant Rev (Orlando) 2008, 22(3):206-209.